Enviracor J-5

This page contains information on Enviracor J-5 for veterinary use.
The information provided typically includes the following:

Enviracor J-5 Indications
Warnings and cautions for Enviracor J-5
Direction and dosage information for Enviracor J-5

Enviracor J-5

This treatment applies to the following species:

Dairy Cattle

Company: Zoetis

Escherichia Coli Bacterin

This product has been shown to be effective for the vaccination of healthy dairy cattle against shedding of E. coli in the milk due to mastitis. Duration of immunity has not been established. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Directions For Use

Shake well. Three doses are required. Administer each 5-mL dose subcutaneously, one hand-width cranial to the shoulder. Vaccinate cows or heifers at 7 and 8 months of gestation followed by the third dose within two weeks postpartum.

Precautions

Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened. Do not vaccinate within 60 days before slaughter. Local swelling occasionally occurs and may persist at the injection site. Contains thimerosal as a preservative. Do not mix with other products. In case of human exposure, contact a physician. In case of anaphylactoid reactions, epinephrine should be administered immediately.

Technical inquiries should be directed to Zoetis Inc. Technical Services, (888) 963-8471.

Mfd by: Poultry Health Laboratories (A Division of PHL Associates, Inc.), Davis, CA 95616

(530) 753-5881

VLN 357/PCN 2648.00

Dist by: Zoetis Inc., Kalamazoo, MI 49007, USA

	NDC
100 mL (20 doses)	0009-3637-05	51106701
250 mL (50 doses)	0009-3637-06	51106301

CPN: 3690348.5

ZOETIS INC.
333 PORTAGE STREET, KALAMAZOO, MI, 49007

Telephone:		269-359-4414
Customer Service:		888-963-8471
Website:		www.zoetis.com

THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.